Zobrazeno 1 - 10
of 729
pro vyhledávání: '"Schageman J"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NSCLC ranges from 2% to 7%. The primary standard diagnostic method is fluorescence in situ hybridization (FISH). Recently, immunohistochemistry (IHC) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2a7593a2d3ab8d4d6ce01fff07c107d0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107651
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107651
Autor:
Deveson IW; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Gong B; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Lai K; Bioinformatics, Integrated DNA Technologies, Inc., Coralville, IA, USA., LoCoco JS; Illumina, Inc., San Diego, CA, USA., Richmond TA; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Schageman J; Clinical Sequencing Division, Thermo Fisher Scientific, Austin, TX, USA., Zhang Z; Research and Development, Burning Rock Biotech, Shanghai, China., Novoradovskaya N; Agilent Technologies, La Jolla, CA, USA., Willey JC; Departments of Medicine, Pathology, and Cancer Biology, College of Medicine and Life Sciences, University of Toledo Health Sciences Campus, Toledo, OH, USA., Jones W; Q2 Solutions - EA Genomics, Morrisville, NC, USA., Kusko R; Immuneering Corporation, Cambridge, MA, USA., Chen G; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA., Madala BS; Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia., Blackburn J; Cancer Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia., Stevanovski I; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia., Bhandari A; ResearchDx, Inc., Irvine, CA, USA., Close D; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA., Conroy J; OmniSeq, Inc., Buffalo, NY, USA., Hubank M; NIHR Biomedical Research Centre, Royal Marsden Hospital, Sutton, Surrey, UK., Marella N; Cancer Genetics, Inc., Rutherford, NJ, USA., Mieczkowski PA; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Qiu F; Research and Development, Burning Rock Biotech, Shanghai, China., Sebra R; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Stetson D; Astrazeneca Pharmaceuticals, Waltham, MA, USA., Sun L; Elim Biopharmaceuticals, Inc., Hayward, CA, USA., Szankasi P; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA., Tan H; Primbio Genes Biotechnology, East Lake High-tech Development Zone, Wuhan, Hubei, China., Tang LY; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA., Arib H; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Best H; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA.; Departments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA., Burgher B; OmniSeq, Inc., Buffalo, NY, USA., Bushel PR; National Institute of Environmental Health Sciences, Research Triangle Park, Morrisville, NC, USA., Casey F; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Cawley S; Clinical Sequencing Division, Thermo Fisher Scientific, South San Francisco, CA, USA., Chang CJ; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA., Choi J; Roche Sequencing Solutions, Inc., Pleasanton, CA, USA., Dinis J; Roche Sequencing Solutions, Inc., Pleasanton, CA, USA., Duncan D; Cancer Genetics, Inc., Rutherford, NJ, USA., Eterovic AK; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA., Feng L; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Ghosal A; ResearchDx, Inc., Irvine, CA, USA., Giorda K; Marketing, Integrated DNA Technologies, Inc., Coralville, IA, USA., Glenn S; OmniSeq, Inc., Buffalo, NY, USA., Happe S; Agilent Technologies, Cedar Creek, TX, USA., Haseley N; Illumina, Inc., San Diego, CA, USA., Horvath K; ResearchDx, Inc., Irvine, CA, USA., Hung LY; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Jarosz M; NGS Products and Services, Integrated DNA Technologies, Inc., Coralville, IA, USA., Kushwaha G; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Li D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Li QZ; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA., Li Z; Intramural Research Program, Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Liu LC; Clinical Diagnostic Division, Thermo Fisher Scientific, Fremont, CA, USA., Liu Z; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Ma C; Cancer Genetics, Inc., Rutherford, NJ, USA., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY, USA., Megherbi DB; CMINDS Research Center, Department of Electrical and Computer Engineering, College of Engineering, University of Massachusetts Lowell, Lowell, MA, USA., Morrison T; Accugenomics, Inc., Wilmington, NC, USA., Pabón-Peña C; Agilent Technologies, Santa Clara, CA, USA., Pirooznia M; Bioinformatics and Computational Biology Laboratory, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Proszek PZ; NIHR Biomedical Research Centre, Royal Marsden Hospital, Sutton, Surrey, UK., Raymond A; Astrazeneca Pharmaceuticals, Waltham, MA, USA., Rindler P; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA., Ringler R; ResearchDx, Inc., Irvine, CA, USA., Scherer A; Institute for Molecular Medicine Finland (FIMM), Nordic EMBL Partnership for Molecular Medicine, HiLIFE Unit, Biomedicum Helsinki 2U (D302b), University of Helsinki, Helsinki, Finland.; EATRIS ERIC- European Infrastructure for Translational Medicine, Amsterdam, The Netherlands., Shaknovich R; Cancer Genetics, Inc., Rutherford, NJ, USA., Shi T; Center for Bioinformatics and Computational Biology and the Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China., Smith M; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Song P; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA., Strahl M; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Thodima VJ; Cancer Genetics, Inc., Rutherford, NJ, USA., Tom N; EATRIS ERIC- European Infrastructure for Translational Medicine, Amsterdam, The Netherlands.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Verma S; ResearchDx, Inc., Irvine, CA, USA., Wang J; Research and Development, Integrated DNA Technologies, Inc., Coralville, IA, USA., Wu L; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Xiao W; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Xu C; Research and Development, QIAGEN Sciences, Inc., Frederick, MD, USA., Yang M; Department of Information Science, University of Arkansas at Little Rock, Little Rock, AR, USA., Zhang G; Clinical Laboratory, Burning Rock Biotech, Guangzhou, China., Zhang S; Clinical Laboratory, Burning Rock Biotech, Guangzhou, China., Zhang Y; Elim Biopharmaceuticals, Inc., Hayward, CA, USA., Shi L; State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Hospital/Cancer Institute, Fudan University, Shanghai, China.; Human Phenome Institute, Fudan University, Shanghai, China.; Fudan-Gospel Joint Research Center for Precision Medicine, Fudan University, Shanghai, China., Tong W; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Johann DJ Jr; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. djjohann@uams.edu., Mercer TR; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. t.mercer@garvan.org.au.; Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia. t.mercer@garvan.org.au.; Australian Institute of Bioengineering and Nanotechnology, University of Queensland, Queensland, QLD, Australia. t.mercer@garvan.org.au., Xu J; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA. joshua.xu@fda.hhs.gov.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2021 Sep; Vol. 39 (9), pp. 1115-1128. Date of Electronic Publication: 2021 Apr 12.
Autor:
Lee CS; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea., Kim HS; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea., Schageman J; Thermo Fisher Scientific, Austin, TX 78701, USA., Lee IK; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea., Kim M; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea., Kim Y; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.; Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Aug 20; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 20.
Autor:
Tang, Haozhou1,2 (AUTHOR), Yu, Dan1 (AUTHOR), Zhang, Jiahui1 (AUTHOR), Wang, Maoye1 (AUTHOR), Fu, Min1 (AUTHOR), Qian, Yu1 (AUTHOR), Zhang, Xiaoxin1 (AUTHOR), Ji, Runbi1 (AUTHOR), Gu, Jianmei3,4 (AUTHOR) gujianmei2010@163.com, Zhang, Xu1 (AUTHOR) xuzhang@ujs.edu.cn
Publikováno v:
Journal of Nanobiotechnology. 10/8/2024, Vol. 22 Issue 1, p1-23. 23p.
Autor:
Shimane, Gaku1 (AUTHOR), Nakano, Yutaka1 (AUTHOR), Matsuda, Sachiko1 (AUTHOR), Kitago, Minoru1 (AUTHOR) dragonpegasus@keio.jp, Masugi, Yohei2 (AUTHOR), Nakamura, Kohei3 (AUTHOR), Nakamura, Yuki1 (AUTHOR), Yagi, Hiroshi1 (AUTHOR), Abe, Yuta1 (AUTHOR), Hasegawa, Yasushi1 (AUTHOR), Hori, Shutaro1 (AUTHOR), Tanaka, Masayuki1 (AUTHOR), Takemura, Ryo4 (AUTHOR), Nishihara, Hiroshi3 (AUTHOR), Kitagawa, Yuko1 (AUTHOR)
Publikováno v:
Scientific Reports. 9/17/2024, Vol. 14 Issue 1, p1-12. 12p.
Autor:
Akbari-Gharalari, Naeimeh1, Khodakarimi, Sina1, Nezhadshahmohammad, Farshad2, Karimipour, Mohammad3, Ebrahimi-Kalan, Abbas1 Abbasebra@gmail.com, Jiagian Wu4,5,6
Publikováno v:
BioImpacts. Sep2024, Vol. 14 Issue 5, p1-17. 17p.
Autor:
Achour B; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Al-Majdoub ZM; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Grybos-Gajniak A; Illumina, Cambridge, UK., Lea K; Thermo Fisher Scientific, Austin, Texas, USA., Kilford P; Simcyp Division, Certara Ltd., Sheffield, UK., Zhang M; Simcyp Division, Certara Ltd., Sheffield, UK., Knight D; Biological Mass Spectrometry Core Facility, University of Manchester, Manchester, UK., Barber J; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Schageman J; Thermo Fisher Scientific, Austin, Texas, USA., Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK.; Certara Ltd., Princeton, New Jersey, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Jan; Vol. 109 (1), pp. 222-232. Date of Electronic Publication: 2020 Nov 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.